Cancer screening study for HIV-infected patients by blood transfusion

JRCT ID: jRCT1032220397

Registered date:20/10/2022

Basic Information

• Recruitment status: Not Recruiting
• Health condition(s) or Problem(s) studied: HIV infection
• Date of first enrollment: 27/10/2022
• Target sample size: 80
• Study type: Interventional

Intervention(s)

Chest and abdominal CT scan including thyroid and prostate,gastric endoscopy,stool occult blood,tumor
markers of AFP,CEA,PSA( men), CA125(female) ,and HIV-pro-viral DNA are perfor med twice with
over one-year interval for the NADM screening.

Outcome(s)

Primary Outcome

To demonstrate incidence(per 100 person-year) of the NADM among HIV infected patients by blood
transfusion

• Secondary Outcome: Identification of the risk factors for NADM among HIV infected patients by blood transfusion

Key inclusion & exclusion criteria

• Age minimum: >= 20age old
• Age maximum: Not applicable
• Gender: Both

Include criteria

1.HIV infected person caused by transfusions of HIV-tainted blood products
2.A written informed consent was obtained

Exclude criteria

1.Severe underlying and/or active AIDS disease that need to be treated
2.Patients who have difficulty to participate in this study due to psychological disease
3.Patients who are judged to be inappropriate in participation by the attending docter

Related Information

• Primary Sponsor: Uemura Haruka
• Source(s) of Monetary Support: Ministry of Health,Labour and Welfare